INVITROGEN CORP
S-3, EX-15.2, 2000-12-28
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: INVITROGEN CORP, S-3, EX-15.1, 2000-12-28
Next: INVITROGEN CORP, S-3, EX-23.2, 2000-12-28



<PAGE>

                                                          EXHIBIT 15.2


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

Commissioners:

We are aware that our report dated July 18, 2000 on our review of the interim
financial information of Dexter Corporation as of June 30, 2000 and for the
three-month and six-month periods ended June 30, 2000 and 1999 included in
the Company's quarterly report on Form 10-Q for the quarter ended June 30,
2000, and our report dated April 13, 2000 on our review of the interim
financial information of the Dexter Corporation as of March 31, 2000 and for
the three-month periods ended March 31, 2000 and 1999 included in the
Company's quarterly report on Form 10-Q for the quarter ended March 31, 2000,
are incorporated by reference in this Registration Statement on Form S-3 of
Invitrogen Corporation.

Very truly yours,



/s/ PricewaterhouseCoopers LLP

Hartford, Connecticut
December 26, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission